680 related articles for article (PubMed ID: 19361557)
1. Amphetamine-induced abnormal movements occur independently of both transplant- and host-derived serotonin innervation following neural grafting in a rat model of Parkinson's disease.
Lane EL; Brundin P; Cenci MA
Neurobiol Dis; 2009 Jul; 35(1):42-51. PubMed ID: 19361557
[TBL] [Abstract][Full Text] [Related]
2. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.
Lane EL; Soulet D; Vercammen L; Cenci MA; Brundin P
Neurobiol Dis; 2008 Nov; 32(2):220-8. PubMed ID: 18675359
[TBL] [Abstract][Full Text] [Related]
3. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
Carlsson T; Carta M; Muñoz A; Mattsson B; Winkler C; Kirik D; Björklund A
Brain; 2009 Feb; 132(Pt 2):319-35. PubMed ID: 19039008
[TBL] [Abstract][Full Text] [Related]
4. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.
Shin E; Garcia J; Winkler C; Björklund A; Carta M
Neurobiol Dis; 2012 Sep; 47(3):393-406. PubMed ID: 22579773
[TBL] [Abstract][Full Text] [Related]
5. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
Dupre KB; Eskow KL; Negron G; Bishop C
Brain Res; 2007 Jul; 1158():135-43. PubMed ID: 17553470
[TBL] [Abstract][Full Text] [Related]
6. Host brain regulation of dopaminergic grafts function: role of the serotonergic and noradrenergic systems in amphetamine-induced responses.
Muñoz A; Rodriguez-Pallares J; Guerra MJ; Labandeira-Garcia JL
Synapse; 2003 Jan; 47(1):66-76. PubMed ID: 12422375
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of L-DOPA co-administered with the adenosine A2A receptor agonist CGS 21680 in an animal model of Parkinson's disease.
Agnati LF; Leo G; Vergoni AV; Martínez E; Hockemeyer J; Lluis C; Franco R; Fuxe K; Ferré S
Brain Res Bull; 2004 Aug; 64(2):155-64. PubMed ID: 15342103
[TBL] [Abstract][Full Text] [Related]
8. Priming for L-DOPA-induced abnormal involuntary movements increases the severity of amphetamine-induced dyskinesia in grafted rats.
Lane EL; Vercammen L; Cenci MA; Brundin P
Exp Neurol; 2009 Sep; 219(1):355-8. PubMed ID: 19393238
[TBL] [Abstract][Full Text] [Related]
9. Amphetamine-induced dyskinesia in the transplanted hemi-Parkinsonian mouse.
Smith GA; Heuer A; Klein A; Vinh NN; Dunnett SB; Lane EL
J Parkinsons Dis; 2012; 2(2):107-13. PubMed ID: 23933747
[TBL] [Abstract][Full Text] [Related]
10. Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats.
Carta M; Carlsson T; Kirik D; Björklund A
Brain; 2007 Jul; 130(Pt 7):1819-33. PubMed ID: 17452372
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive use of the non-ionic surfactant Poloxamer 188 improves fetal dopaminergic cell survival and reinnervation in a neural transplantation strategy for Parkinson's disease.
Quinn M; Mukhida K; Sadi D; Hong M; Mendez I
Eur J Neurosci; 2008 Jan; 27(1):43-52. PubMed ID: 18093176
[TBL] [Abstract][Full Text] [Related]
12. Dissociation between short-term increased graft survival and long-term functional improvements in Parkinsonian rats overexpressing glial cell line-derived neurotrophic factor.
Georgievska B; Carlsson T; Lacar B; Winkler C; Kirik D
Eur J Neurosci; 2004 Dec; 20(11):3121-30. PubMed ID: 15579166
[TBL] [Abstract][Full Text] [Related]
13. Role of serotonin neurons in the induction of levodopa- and graft-induced dyskinesias in Parkinson's disease.
Carta M; Carlsson T; Muñoz A; Kirik D; Björklund A
Mov Disord; 2010; 25 Suppl 1():S174-9. PubMed ID: 20187238
[TBL] [Abstract][Full Text] [Related]
14. Functional effect of FGF2- and FGF8-expanded ventral mesencephalic precursor cells in a rat model of Parkinson's disease.
Jensen P; Pedersen EG; Zimmer J; Widmer HR; Meyer M
Brain Res; 2008 Jul; 1218():13-20. PubMed ID: 18513704
[TBL] [Abstract][Full Text] [Related]
15. Influence of time in culture and BDNF pretreatment on survival and function of grafted embryonic rat ventral mesencephalon in the 6-OHDA rat model of Parkinson's disease.
Höglinger GU; Widmer HR; Spenger C; Meyer M; Seiler RW; Oertel WH; Sautter J
Exp Neurol; 2001 Jan; 167(1):148-57. PubMed ID: 11161602
[TBL] [Abstract][Full Text] [Related]
16. Graft placement and uneven pattern of reinnervation in the striatum is important for development of graft-induced dyskinesia.
Carlsson T; Winkler C; Lundblad M; Cenci MA; Björklund A; Kirik D
Neurobiol Dis; 2006 Mar; 21(3):657-68. PubMed ID: 16256359
[TBL] [Abstract][Full Text] [Related]
17. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats.
Steece-Collier K; Collier TJ; Danielson PD; Kurlan R; Yurek DM; Sladek JR
Mov Disord; 2003 Dec; 18(12):1442-54. PubMed ID: 14673880
[TBL] [Abstract][Full Text] [Related]
18. Neurorescue effects of VEGF on a rat model of Parkinson's disease.
Yasuhara T; Shingo T; Muraoka K; Kameda M; Agari T; Wen Ji Y; Hayase H; Hamada H; Borlongan CV; Date I
Brain Res; 2005 Aug; 1053(1-2):10-8. PubMed ID: 16045899
[TBL] [Abstract][Full Text] [Related]
19. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
20. Effects of group I metabotropic glutamate receptors blockade in experimental models of Parkinson's disease.
Dekundy A; Pietraszek M; Schaefer D; Cenci MA; Danysz W
Brain Res Bull; 2006 Apr; 69(3):318-26. PubMed ID: 16564428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]